Daré Bioscience, Inc. (DARE) Q2 2023 Earnings Call Transcript


Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET

Company Participants

Sabrina Martucci Johnson – President and Chief Executive Officer

John Fair – Chief Commercial Officer

Lisa Walters-Hoffert – Chief Financial Officer

Conference Call Participants

Catherine Novack – Jones Research

Operator

Welcome to the conference hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended June 30, 2023, and to provide a General Business Update. This call is being recorded. My name is Mark and I will be your operator today.

With us today are Sabrina Martucci Johnson, Daré’s President and Chief Executive Officer; John Fair, Daré’s Chief Commercial Officer; and Lisa Walters-Hoffert, Daré’s Chief Financial Officer.

Ms. Johnson, please proceed.

Sabrina Martucci Johnson

Thank you. Good afternoon, and welcome to the financial results and business update call for the quarter ended June 30, 2023 for Daré Bioscience. For those of you joining us via webcast, you should be able to access presentation slides from within the webcast module. We’ve included the slides to provide some additional context on our portfolio that you may find helpful while you listen to the call. The slide deck is also available in the Investor Relations section of our website under Presentations, Events and Webcast and will remain on the site for two weeks.

Today we will review our second quarter results, and discuss developments and expectations for XACIATO commercialization and for two of our late-stage investigational products, our hormone-free monthly, intravaginal contraceptive candidate Ovaprene and Sildenafil Cream 3.6% which is being developed as a treatment for arousal disorder in women.

Before we begin, I would like to remind you that today’s discussion will include forward-looking statements within the meaning of federal securities laws which are made pursuant to the Safe Harbor provisions of the



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *